tiprankstipranks
Medivir AB (MVRBF)
OTHER OTC:MVRBF

Medivir AB (MVRBF) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

MVRBF Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Medivir
AB
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MVRBF Stock 12 Month Forecast

There Are No Analyst Ratings for MVRBF In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

MVRBF Financial Forecast

No data currently available

MVRBF Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

MVRBF Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright
$4.90
Buy
497.31%
Upside
Reiterated
03/14/23
Valuation and risks to price target achievement. We reiterate our Buy rating and our price target of SEK50. Our valuation contributions come from fostrox (61% contribution), remetinostat (33% contribution), and birinipant (6% contribution). We note that we do not account for MIV-711 awaiting partnership to continue its development in osteoarthritis, which we believe represents significant potential upside.
Maxim Group
$3.00
Buy
265.85%
Upside
Reiterated
08/19/22
Medivir reported 2Q22 results this morning with a net loss of ($2.3M) and ended the period with $16.3M in cash on the balance sheet. The company should have sufficient runway into late 2H23.

MVRBF Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

MVRBF Stock Forecast FAQ

What is MVRBF’s average 12-month price target, according to analysts?
Currently, no data Available
What is MVRBF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MVRBF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is MVRBF a Buy, Sell or Hold?
      Currently, no data Available
      What is Medivir AB’s price target?
      Currently, no data Available
      What do analysts say about Medivir AB?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of MVRBF?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis